IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for Ide397 Monotherapy in Mtap-Deletion Squamous Non-Small Cell Lung Cancer
IDEAYA Biosciences宣布为Mtap缺失鳞状非小细胞肺癌的Ide397单一疗法选择向前推进的2期扩张剂量
IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for Ide397 Monotherapy in Mtap-Deletion Squamous Non-Small Cell Lung Cancer
IDEAYA Biosciences宣布为Mtap缺失鳞状非小细胞肺癌的Ide397单一疗法选择向前推进的2期扩张剂量
使用浏览器的分享功能,分享给你的好友吧